Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the Prostate
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
Aminoglutethimide (Elipten-Ciba) as an Inhibitor of Adrenal Steroidogenesis: Mechanism of Action and Therapeutic Trial
1967 • 259 citations
Plasma Testosterone: An Accurate Monitor of Hormone Treatment in Prostatic Cancer
1973 • 167 citations
Effect of Hormonal Therapy on Plasma Testosterone Levels in Prostatic Carcinoma
1971 • 164 citations
Aldosteronism in Hypertension
1968 • 143 citations
Plasma Testosterone Levels in Patients with Prostatic Carcinoma Before and after Treatment
1968 • 94 citations
Cyproterone Acetate in the Treatment of Advanced Carcinoma of the Prostate
1973 • 74 citations
Experience in the Treatment of Prostatic Carcinoma with Cyproterone Acetate
1973 • 73 citations
Studies on Prostatic Cancer. V. Excretion of 17-Ketosteroids, Estrogens and Gonadotropins before and after Castration1
1942 • 64 citations
Spironolactone Therapy and Gynecomastia
1965 • 64 citations
Anti-androgenic activity of spironolactone
1969 • 60 citations
Adrenal androgens in man
1972 • 37 citations
Antiandrogenic Effect of Spironolactone in Rats
1974 • 21 citations
The Effect of Anti-Androgens on the Response of Rat Preputial Glands to Testosterone*
1964 • 18 citations
Cited By (0)
No citing papers found in database